NRX Pharmaceuticals Inc. (NRXP)
NASDAQ · Healthcare
NRX Pharmaceuticals Inc. Total Liabilities 2023–2025
NRX Pharmaceuticals Inc. annual total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- NRX Pharmaceuticals Inc. total liabilities as of December 31, 2025: 28.9M, a 7.51% increase year-over-year.
- NRX Pharmaceuticals Inc. total liabilities for 2025 were 28.9M, a 7.51% increase from 2024.
- NRX Pharmaceuticals Inc. total liabilities for 2024 were 26.9M, a 41.09% increase from 2023.
- NRX Pharmaceuticals Inc. total liabilities for 2023 were 19.0M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| NRX Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $29 |
| 2024 | $27 |
| 2023 | $19 |
NRX Pharmaceuticals Inc. Total Liabilities — FAQ
NRX Pharmaceuticals Inc. (NRXP) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRXP's total liabilities history?
The chart and table above show NRX Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.